S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
OTCMKTS:NEVPF

Abliva AB (publ) (NEVPF) Stock Forecast, Price & News

Compare
Today's Range
N/A
50-Day Range
$0.01
$0.01
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

NEVPF stock logo

About Abliva AB (publ) (OTCMKTS:NEVPF) Stock

Abliva AB (publ), a clinical-stage biotech company, develops medicines for the treatment of primary mitochondrial diseases. The company is developing KL1333 that is in Phase 2/3 clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT that is in Phase 1b/2a clinical study for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.


NEVPF Stock News Headlines

Interfox Resources publ AB (IFOX)
Cell Impact publ AB (CELLI)
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video)
“Hi, I’m Teeka Tiwari...I’m about to get in this Tesla and drive up to a facility just a few miles from here to show you what could be the secret behind Elon Musk’s new AI project… What happens next will shock you…”
Abliva AB (publ) (NEVPF)
BioInvent strengthens Investor Relations
NeuroVive Pharmaceutical AB reports Q4 results
BREAKING: The truth about war with China
Foreign Affairs reports, "China is Now in a Prewar Tempo of Political and Military Preparations." China has one goal: take control of Taiwan, and an invasion could happen any day. I've identified 5 investments I believe are in immediate danger. But you can get out of them now - before it's too late.
NeuroVive settles dispute with CicloMulsion AG
See More Headlines
Receive NEVPF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abliva AB (publ) and its competitors with MarketBeat's FREE daily newsletter.

NEVPF Company Calendar

Today
10/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:NEVPF
CIK
N/A
Employees
8
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$20,000.00
Book Value
$0.01 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2023 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Dr. Ellen K. Donnelly Ph.D. (Age 49)
    Chief Exec. Officer
  • Ms. Catharina Jz Johansson (Age 56)
    Deputy CEO, CFO & VP of Investor Relations
  • Dr. Eskil Elmér (Age 53)
    Chief Scientific Officer & VP of Discovery
  • Daniel Schale
    Director of Communications
  • Dr. Magnus Hansson (Age 47)
    Chief Medical Officer and VP of Preclinical & Clinical Devel.
  • Mr. Dag Nesse
    VP of Clinical Operations
  • Dr. Lars Vedin
    Consultant













NEVPF Stock - Frequently Asked Questions

What is Abliva AB (publ)'s stock symbol?

Abliva AB (publ) trades on the OTCMKTS under the ticker symbol "NEVPF."

How do I buy shares of Abliva AB (publ)?

Shares of NEVPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

How much money does Abliva AB (publ) make?

Abliva AB (publ) (OTCMKTS:NEVPF) has a market capitalization of $0.00 and generates $20,000.00 in revenue each year.

How can I contact Abliva AB (publ)?

Abliva AB (publ)'s mailing address is MEDICON VILLAGE SCHEELEVAGEN 2, LUND V7, 22381. The official website for the company is www.neurovive.com. The company can be reached via phone at (646) 275-6220, via email at ir@abliva.com, or via fax at 46-4-688-883-48.

This page (OTCMKTS:NEVPF) was last updated on 10/4/2023 by MarketBeat.com Staff

My Account -